drugset / Trial / NCT02425202

Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy

NCT02425202 ↗

Phase 4 Completed 36 enrolled University of Manitoba
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study will evaluate the post-operative morphine-sparing effect, pain reduction, and side effects of a continuous ketamine infusion after tonsillectomy in pediatric patients.

Timeline

Start
2014-12
Primary completion
2018-05-03
Completion
2018-05-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.1 mg/kg —